NICE prostate cancer clinical guideline: Implications for primary care

British Journal of General Practice

Volumn 58, Issue 554, 2008, Pages 607-608

  Neal, Richard D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; COMORBIDITY; CONSULTATION; EDITORIAL; EVIDENCE BASED MEDICINE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PROSTATE CANCER; PROSTATE SURGERY; PSYCHOSOCIAL CARE; SYMPTOM; URINARY TRACT OBSTRUCTION;

FAMILY PRACTICE; GREAT BRITAIN; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS;

EID: 51549092935     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp08X330708     Document Type: Editorial

References (7)

1. Cancer Research UK. CancerStats Key Facts on Prostate Cancer. http://info.cancerresearchuk.org/cancerstats/types/prostate/ (accessed 4 Aug 2008).
2. National Institute for Health and Clinical Excellence. Prostate cancer diagnosis and treatment. Cardiff: National Collaborating Centre for Cancer, 2008.
3. National Institute for Clinical Excellence. Supportive and palliative care. London: NICE, 2004.
4. National Institute for Clinical Excellence. Referral guidelines for suspected cancer. London: NICE, 2005.
5. Donovan J, Mills N, Smith M, et al. Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ 2002; 325: 766-770.
6. Neal RD. Management of prostate cancer in general practice. Trends in urology, gynaecology and sexual health 2008: in press.
7. University of Bristol. ProtecT Study (Prostate testing for cancer and Treatment). http://www.epi.bris.ac.uk/protect/ (accessed 4 Aug 2008).